2022
DOI: 10.1002/mco2.118
|View full text |Cite
|
Sign up to set email alerts
|

Graphene and graphene oxide with anticancer applications: Challenges and future perspectives

Abstract: Graphene‐based materials have shown immense pertinence for sensing/imaging, gene/drug delivery, cancer therapy/diagnosis, and tissue engineering/regenerative medicine. Indeed, the large surface area, ease of functionalization, high drug loading capacity, and reactive oxygen species induction potentials have rendered graphene‐ (G‐) and graphene oxide (GO)‐based (nano)structures promising candidates for cancer therapy applications. Various techniques namely liquid‐phase exfoliation, Hummer's method, chemical vap… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(24 citation statements)
references
References 153 publications
0
21
0
Order By: Relevance
“…For example, smaller GO flakes showed, in general, less toxicity. The size of GO is also important to be always taken into account, as a mechanism by which the material internalises into a target cell [244][245][246].…”
Section: Discussionmentioning
confidence: 99%
“…For example, smaller GO flakes showed, in general, less toxicity. The size of GO is also important to be always taken into account, as a mechanism by which the material internalises into a target cell [244][245][246].…”
Section: Discussionmentioning
confidence: 99%
“…The folate receptor is a glycosyl-phosphatidylinositol conjugated glycoprotein that is overexpressed on cancer cell membrane surfaces [ 72 ]. The FA-conjugated probes can be endocytosed via the folate receptor; hence, specific cancer targeting can be achieved [ 8 , 73 ].…”
Section: Graphene-based Photoacoustic Imagingmentioning
confidence: 99%
“…An assortment of nanoparticles and nanoarchitectures has been designed with satisfactory biocompatibility and targeting properties for a wide range of biomedical and clinical applications; however, due to the stringent regulatory necessities, only a handful of them have entered into clinical trials/studies. Nevertheless, these materials have garnered widespread attention from scientists for their deployment as anticancer nanocarriers and nanobiosensors [ 7 , 8 , 9 , 10 , 11 , 12 ].…”
Section: Introductionmentioning
confidence: 99%